Evidence map›Paper›PMID 30543095›Full record

ArticleACS applied materials & interfaces2019

Specific Inhibition of Heparanase by a Glycopolymer with Well-Defined Sulfation Pattern Prevents Breast Cancer Metastasis in Mice.

Ravi S Loka, Eric T Sletten, Uri Barash, Israel Vlodavsky, Hien M Nguyen

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ravi S LokaDepartment of Chemistry , Wayne State University , Detroit , Michigan 48202 , United States.
Eric T SlettenDepartment of Chemistry , University of Iowa , Iowa City, Iowa 52242 , United States.ORCID http://orcid.org/0000-0003-2177-2969
Uri BarashCancer and Vascular Biology Research Center, Rappaport Faculty of Medicine , Technion-Israel Institute of Technology , Haifa , Israel.
Israel VlodavskyCancer and Vascular Biology Research Center, Rappaport Faculty of Medicine , Technion-Israel Institute of Technology , Haifa , Israel.
Hien M NguyenDepartment of Chemistry , Wayne State University , Detroit , Michigan 48202 , United States.ORCID http://orcid.org/0000-0002-7626-8439
Technion – Israel Institute of Technology · ILWayne State University · USUniversity of Iowa · US

Funding

Tailoring Structures of Sulfated Oligosaccharides for Modulating Heparanase ActivityR01GM098285 · NIGMS · WAYNE STATE UNIVERSITY · PI NGUYEN, HIEN M · 2012 to 2022
$3.5M
NIGMS NIH HHS R01 GM098285
6 · The paper itself

Abstract

Heparanase, the heparan sulfate polysaccharide degrading endoglycosidase enzyme, has been correlated with tumor angiogenesis and metastasis and therefore has become a potential target for anticancer drug development. In this systematic study, the sulfation pattern of the pendant disaccharide moiety on synthetic glycopolymers was synthetically manipulated to achieve optimal heparanase inhibition. Upon evaluation, a glycopolymer with 12 repeating units was determined to be the most potent inhibitor of heparanase (IC

Indexed as

GlucuronidaseMammary Neoplasms, ExperimentalNeoplasm ProteinsNeovascularization, PathologicAnimalsCell Line, TumorEnzyme InhibitorsFemaleHeparanaseHeparinHumansHuman Umbilical Vein Endothelial CellsMiceNeoplasm MetastasisP-SelectinEnzyme InhibitorsGlucuronidaseHeparanaseHeparinNeoplasm ProteinsP-Selectinbiolayer interferometrycancer therapeuticglycopolymerheparanasemetastasis

Identifiers

PMID30543095
PMCPMC6512314
OpenAlexW2904796618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.